Combined oxidative phosphorylation defect type 13 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by normal early development followed by the sudden onset in infancy of poor feeding, dysphagia, truncal (followed by global) hypotonia, motor regression, abnormal movements (i.e. severe dystonia of limbs, choreoathetosis, facial dyskinesias) and reduced tendon reflexes. The disease course is severe but nonprogressive.
Comprehensive, easy-to-understand information about this condition
Checking for content...
severe X-linked mitochondrial encephalomyopathy
MONDO:0010437
hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
MONDO:0012191
combined oxidative phosphorylation defect type 2
MONDO:0012510
fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
MONDO:0012512
combined oxidative phosphorylation defect type 4
MONDO:0012534
hypotonia with lactic acidemia and hyperammonemia
MONDO:0012718